Crossmark

Prescription of PARP inhibitors (iPARP) in metastatic castration-resistant prostate cancer: a position paper of the Spanish Association of Urology (AEU) and its Uro-Oncology Group (GUO)

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2026.501898

Published Print: 2026-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

González Enguita, C.

Pérez Fentes, D. https://orcid.org/0000-0001-6348-8646
Budía Alba, A.

Lorenzo Gómez, M.F.

Gómez Rivas, J.

Manso Aparicio, C.

Fernández Aparicio, T.

Alvárez-Ossorio Fernández, J.L.
License Information

Text and Data Mining valid from 2026-03-01

Text and Data Mining valid from 2026-03-01
More Information

This article is maintained by: Elsevier

Article Title: Prescription of PARP inhibitors (iPARP) in metastatic castration-resistant prostate cancer: a position paper of the Spanish Association of Urology (AEU) and its Uro-Oncology Group (GUO)

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2026.501898

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2025.501898

Content Type: article

Copyright: © 2025 AEU. Published by Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Document is current

Any future updates will be listed below